1. Home
  2. CING

CING

Cingulate Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-17-2024 2:34pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Founded: 2012 Country:
United States
United States
Employees: N/A City: KANSAS CITY
Market Cap: 5.1M IPO Year: 2021
Target Price: $8.00 AVG Volume (30 days): 318.9K
Analyst Decision: Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -26.00 EPS Growth: N/A
52 Week Low/High: $0.92 - $23.80 Next Earning Date: 05-08-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: